Skip to content

Efficacy and safety of oral soy extract recipe product on anti-skin aging of postmenopausal women

Efficacy and safety of oral soy extract recipe product on anti-skin aging of postmenopausal women

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20220707001
Enrollment
100
Registered
2022-07-07
Start date
2023-01-23
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postmenopausal women Postmenopausal, soy extract, anti-skin aging

Interventions

Soy extract recipe product, administered 2 capsules twice daily (12 weeks). ,The placebo will be the instant powder, prepared in an identical appearance and flavor but without soy extract, administere
Soy extract recipe product,Placebo

Sponsors

Chiang Mai University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
48 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Healthy volunteers (based on medical history and physical examination) and > 1 year postmenopausal, 2) FSH > 30 mU/mL, 3) Body mass index (BMI) 18-30 kg/m2.

Exclusion criteria

Exclusion criteria: 1) Known contraindication or hypersensitivity to soybean and other soya products, 2) Treatment with estrogens or isoflavone for the previous 6 months, 3) Taking retinoids, vitamin, minerals, herbal substances, antibiotics, steroids, or immunosuppressants within 3 months prior to enrollment, 4) A history of chronic disorders related to renal, liver, cardiovascular, brain, GI, blood or thyroid, 5) Regular consumption of alcohol, cigarette smoking, or recreational drugs use/addiction.

Design outcomes

Primary

MeasureTime frame
Skin Evaluation at 0 and 12 weeks after end of the intervention Visiometer, Visiopor, Corneometer, Colorimeter, Cutometer

Secondary

MeasureTime frame
Quality of life at 12 weeks after end of the intervention The MENQOL questionnaire,Vasomotor symptoms at 12 weeks after end of the intervention The Modified Kupperman Index,Bone turnover markers at 12 weeks after end of the intervention Osteocalcin, TotalP1NP and Beta-crosslaps

Countries

Thailand

Contacts

Public ContactSupanimit Teekachunhatean

Chiang Mai university

supanimit.t@cmu.ac.th053935351

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026